Avert-IT

Intensive Care patients can experience Adverse Events associated with sudden episodes of low blood pressure. These Adverse Events may impact all of the main organs resulting in longer lengths of stay, increased care costs and reducing quality of outcomes. Existing technologies enable to clinicians to know when these events have occurred and treat the effects.

Medical techniques for avoiding Adverse Events currently exist, but clinicians don#t have a reliable way to predict the occurrence, so there is no opportunity for intervention.

Research indicates average lengths of stay can be reduced by up to 30%, and outcomes improved for a similar proportion of patients, if these Adverse Events can be avoided through prediction and intervention. Potential savings across the EU exceed 5 billion euros, annually.

A model for predicting Adverse Events offers potential for improving outcomes across a wide range of conditions and or illnesses.

The main objectives of the project are:

  • Understanding the association between multiple patient parameters and arterial hypotension (sudden drop in blood pressure)
  • Development of a software application to predict the occurrence of arterial hypotension based on recognition of the associations described above
  • Validation of the solution in clinical trials
  • Exploitation model for the commercialisation of the software in product/service sales across international markets

For further information, please visit:
http://avertit.wordpress.com (Avert-IT Project Blog)

Project co-ordinator:
Pera Innovation Ltd.

Partners:

  • C3 Amulet Ltd
  • Uppsala Universitet
  • Universitätsklinikum Heidelberg
  • Azienda Ospedaleria San Gerardo Di Monza
  • Kauno Technologijos Universitetas
  • The University Of Glasgow
  • Greater Glasgow Health Board
  • Hospital Universitari Vall d'Hebron
  • Philips Medizin Systeme Böblingen Gmbh.

Timetable: from 01/2008 € to 12/2010

Total cost: € 2.286.138

EC funding: € 1.780.000

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

mHealth as Effective as Clinic-Based Int…

A mobile health (mHealth) intervention was found to be as effective as a clinic-based group intervention for people with serious mental illness in a new study published online in Psychiatric...

Mobile Health Technology can Potentially…

Mobile health technology has the potential to transform the way we prevent and manage heart disease, but there are unanswered questions about how to optimize this technology and maintain engagement...

New Computational Tool could Help Optimi…

Scientists have developed a novel computational approach that incorporates individual patients' brain activity to calculate optimal, personalized brain stimulation treatment for Alzheimer's disease. Lazaro Sanchez-Rodriguez of the University of Calgary...

First Call for Science and Technology at…

Participate in the first ever ESC Digital Health Call for Technology, for the chance to present your innovations, your technology or your products at ESC Congress 2018 in front of...

Siemens Healthineers Assists Swiss Post …

To expand its portfolio in the area of eHealth, Swiss Post will make use of the Siemens Healthineers eHealth Solutions(1) in the future. The eHealth solution offered by Swiss Post...

Philips Expands its Therapeutic Care Bus…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that it has acquired Remote Diagnostic Technologies (RDT), a UK-based leading innovator of advanced solutions for the...

Joined-Up Health & Care Conference M…

InterSystems, a global leader in health information technology, will be celebrating a double anniversary at its annual Joined-Up Health & Care conference. This year’s event at The Belfry, Sutton Coldfield...

Ingestible 'Bacteria on a Chip' could He…

MIT researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. This "bacteria-on-a-chip" approach combines sensors made from...

FDA Takes New Steps to Advance Digital H…

Today, the FDA is opening a docket to solicit feedback on important provisions of the 21st Century Cures Act ("Cures Act"). The Cures Act amended the Federal Food, Drug, and...

Mobile App for Autism Screening Yields U…

A Duke study of an iPhone app to screen young children for signs of autism has found that the app is easy to use, welcomed by caregivers and good at...

Open Call MSCA-IF-2018: Individual Fello…

The goal of the Individual Fellowships is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced...

Lexmark Partners with NHS Shared Busines…

Lexmark, a global imaging solutions leader, today announced a partnership with NHS Shared Business Services (NHS SBS) to enable the public sector to utilise Lexmark technology to support their aim...